SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001213900-22-024570
Filing Date
2022-05-06
Accepted
2022-05-06 17:00:52
Documents
6
Effectiveness Date
2022-05-06

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea159515-s8_virpaxpharma.htm S-8 97575
2 LEGAL OPINION OF LOWENSTEIN SANDLER LLP ea159515ex5-1_virpaxpharma.htm EX-5.1 6837
3 CONSENT OF EISNERAMPER LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM ea159515ex23-1_virpaxpharma.htm EX-23.1 2082
4 FILING FEE TABLE ea159515ex-fee_virpaxpharma.htm EX-FILING FEES 21828
5 GRAPHIC ex5-1_001.jpg GRAPHIC 4333
6 GRAPHIC ex5-1_002.jpg GRAPHIC 10453
  Complete submission text file 0001213900-22-024570.txt   150048
Mailing Address 1554 PAOLI PIKE #279 WEST CHESTER PA 19380
Business Address 1554 PAOLI PIKE #279 WEST CHESTER PA 19380 484-875-3195
Virpax Pharmaceuticals, Inc. (Filer) CIK: 0001708331 (see all company filings)

IRS No.: 821510982 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-264767 | Film No.: 22902180
SIC: 2834 Pharmaceutical Preparations